Hugh McMillan

Professor, Department of Pediatrics, University of Ottawa

Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario

Email Hugh

Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa.  He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute

He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook.  He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.

Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.

Dr. Hugh McMillan profile picture.

Read more about Hugh

Recent publications

Jaremek, A, Chisvin, R, Kutcher, SA, Webster, RJ, Kazoun, F, Goldbloom, EB et al.. Decreased Incidence of Pediatric Neuro-Autoimmune Disorders During COVID-19 Pandemic Restrictions. J Child Neurol. 2024. 8830738241293503 PMID:39574034

Del Gobbo, GF, Wang, X, MacDonald, SK, Liang, Y, Care4Rare Canada Consortium, McMillan, HJ et al.. A Novel De Novo Splice Acceptor Variant in BICD2 Is Associated With Spinal Muscular Atrophy. Am J Med Genet A. 2024. e63944 PMID:39559931

McMillan, HJ, Gonorazky, H, Campbell, C, Chrestian, N, Crone, M, Dowling, JJ et al.. Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies. Can J Neurol Sci. 2024. 1-7 PMID:39534980

Gotfrit, R, Wilson, N, Matzinger, M, McMillan, HJ. Internal Carotid Arteritis Associated with Sinusitis in a Child: Potential Benefit of Corticosteroids. Can J Neurol Sci. 2024. 1-3 PMID:39450494

Maglalang, PD, Sinha, J, Zimmerman, K, McCann, S, Edginton, A, Hornik, CP et al.. Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population. Clin Pharmacokinet. 2024.63 (6)885-899 PMID:38814425

Freeman, E, Langlois, S, Leyba, MF, Ammar, T, Léger, Z, McMillan, HJ et al.. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice. Skelet Muscle. 2024.14 (1)8 PMID:38671506

Dang, UJ, Damsker, JM, Guglieri, M, Clemens, PR, Perlman, SJ, Smith, EC et al.. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial. Neurology. 2024.102 (5)e208112 PMID:38335499

Muntoni, F, Byrne, BJ, McMillan, HJ, Ryan, MM, Wong, BL, Dukart, J et al.. The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. Neurol Ther. 2024.13 (1)183-219 PMID:38190001

Longmuir, PE, Chubbs Payne, A, Beshara, N, Brandão, LR, Wright, FV, Pohl, D et al.. Quick, Effective Screening Tasks Identify Children With Medical Conditions or Disabilities Needing Physical Literacy Support. Pediatr Exerc Sci. 2024. 1-11 PMID:38171358

Baranello, G, Neurodevelopment in SMA Working Group. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy. Eur J Paediatr Neurol. 2024.48 67-68 PMID:38043384

See more on PubMed